(MTRN) Materion - Overview
Stock: Alloys, Beryllium, Composites, Chemicals, Optics
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.55% |
| Yield on Cost 5y | 0.99% |
| Yield CAGR 5y | 3.97% |
| Payout Consistency | 70.2% |
| Payout Ratio | 14.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 39.3% |
| Relative Tail Risk | -9.93% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.14 |
| Alpha | 39.03 |
| Character TTM | |
|---|---|
| Beta | 1.049 |
| Beta Downside | 1.120 |
| Drawdowns 3y | |
|---|---|
| Max DD | 47.84% |
| CAGR/Max DD | 0.44 |
Description: MTRN Materion January 13, 2026
Materion Corporation (NYSE:MTRN) manufactures advanced engineered materials across four segments-Performance Materials, Electronic Materials, Precision Optics, and Other-serving semiconductor, aerospace & defense, automotive, energy, consumer electronics, and life-science markets. Its product slate includes beryllium and non-beryllium alloy systems, ToughMet alloys, SupremEX aluminum-silicon-carbide composites, precision thin-film coatings, and specialty chemicals, with a vertically integrated bertrandite ore mine that supplies beryllium hydroxide for internal use and external sales.
In FY 2023 the company reported revenue of roughly $1.3 billion and an adjusted EBITDA margin near 12%, reflecting the high-value nature of its specialty metal products. A key economic driver is the defense-spending surge and the growing demand for lightweight, high-temperature materials in next-generation aircraft and hypersonic programs, which historically boost beryllium and ToughMet sales. Conversely, the semiconductor cycle introduces volatility; a slowdown in chip fab expansions could pressure the Electronic Materials segment, while a rebound would likely lift demand for high-purity metal targets and packaging solutions.
Recent sector trends-such as the electrification of transportation and the push for higher-performance batteries-are expanding the market for engineered metal matrix composites, positioning Materion to benefit from rising OEM spending on lightweight structures. For a deeper quantitative view, the ValueRay platform offers a granular breakdown of Materion’s financials and peer comparisons.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 19.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 5.19 > 1.0 |
| NWC/Revenue: 31.30% < 20% (prev 32.51%; Δ -1.21% < -1%) |
| CFO/TA 0.09 > 3% & CFO 157.1m > Net Income 19.4m |
| Net Debt (515.3m) to EBITDA (211.8m): 2.43 < 3 |
| Current Ratio: 3.29 > 1.5 & < 3 |
| Outstanding Shares: last quarter (20.9m) vs 12m ago -0.13% < -2% |
| Gross Margin: 19.20% > 18% (prev 0.19%; Δ 1901 % > 0.5%) |
| Asset Turnover: 94.64% > 50% (prev 89.86%; Δ 4.78% > 0%) |
| Interest Coverage Ratio: 4.58 > 6 (EBITDA TTM 211.8m / Interest Expense TTM 31.5m) |
Altman Z'' 5.64
| A: 0.30 (Total Current Assets 776.3m - Total Current Liabilities 235.6m) / Total Assets 1.79b |
| B: 0.51 (Retained Earnings 908.7m / Total Assets 1.79b) |
| C: 0.08 (EBIT TTM 144.5m / Avg Total Assets 1.83b) |
| D: 1.40 (Book Value of Equity 1.20b / Total Liabilities 858.6m) |
| Altman-Z'' Score: 5.64 = AAA |
Beneish M -3.27
| DSRI: 0.88 (Receivables 195.3m/214.6m, Revenue 1.73b/1.67b) |
| GMI: 0.97 (GM 19.20% / 18.56%) |
| AQI: 0.90 (AQ_t 0.23 / AQ_t-1 0.26) |
| SGI: 1.04 (Revenue 1.73b / 1.67b) |
| TATA: -0.08 (NI 19.4m - CFO 157.1m) / TA 1.79b) |
| Beneish M-Score: -3.27 (Cap -4..+1) = AA |
What is the price of MTRN shares?
Over the past week, the price has changed by +12.14%, over one month by +16.91%, over three months by +36.15% and over the past year by +53.01%.
Is MTRN a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MTRN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 151.3 | -0.2% |
| Analysts Target Price | 151.3 | -0.2% |
| ValueRay Target Price | 182.9 | 20.6% |
MTRN Fundamental Data Overview February 05, 2026
P/E Forward = 23.31
P/S = 1.7342
P/B = 3.2169
P/EG = 2.35
Revenue TTM = 1.73b USD
EBIT TTM = 144.5m USD
EBITDA TTM = 211.8m USD
Long Term Debt = 446.8m USD (from longTermDebt, last quarter)
Short Term Debt = 10.2m USD (from shortTermDebt, last quarter)
Debt = 531.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 515.3m USD (from netDebt column, last quarter)
Enterprise Value = 3.52b USD (3.01b + Debt 531.7m - CCE 16.4m)
Interest Coverage Ratio = 4.58 (Ebit TTM 144.5m / Interest Expense TTM 31.5m)
EV/FCF = 44.73x (Enterprise Value 3.52b / FCF TTM 78.7m)
FCF Yield = 2.24% (FCF TTM 78.7m / Enterprise Value 3.52b)
FCF Margin = 4.56% (FCF TTM 78.7m / Revenue TTM 1.73b)
Net Margin = 1.12% (Net Income TTM 19.4m / Revenue TTM 1.73b)
Gross Margin = 19.20% ((Revenue TTM 1.73b - Cost of Revenue TTM 1.40b) / Revenue TTM)
Gross Margin QoQ = 18.19% (prev 19.15%)
Tobins Q-Ratio = 1.96 (Enterprise Value 3.52b / Total Assets 1.79b)
Interest Expense / Debt = 1.57% (Interest Expense 8.34m / Debt 531.7m)
Taxrate = 9.60% (2.70m / 28.1m)
NOPAT = 130.6m (EBIT 144.5m * (1 - 9.60%))
Current Ratio = 3.29 (Total Current Assets 776.3m / Total Current Liabilities 235.6m)
Debt / Equity = 0.57 (Debt 531.7m / totalStockholderEquity, last quarter 934.6m)
Debt / EBITDA = 2.43 (Net Debt 515.3m / EBITDA 211.8m)
Debt / FCF = 6.55 (Net Debt 515.3m / FCF TTM 78.7m)
Total Stockholder Equity = 900.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.06% (Net Income 19.4m / Total Assets 1.79b)
RoE = 2.15% (Net Income TTM 19.4m / Total Stockholder Equity 900.5m)
RoCE = 10.72% (EBIT 144.5m / Capital Employed (Equity 900.5m + L.T.Debt 446.8m))
RoIC = 9.71% (NOPAT 130.6m / Invested Capital 1.34b)
WACC = 8.52% (E(3.01b)/V(3.54b) * Re(9.78%) + D(531.7m)/V(3.54b) * Rd(1.57%) * (1-Tc(0.10)))
Discount Rate = 9.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.10%
[DCF Debug] Terminal Value 67.87% ; FCFF base≈78.7m ; Y1≈51.7m ; Y5≈23.6m
Fair Price DCF = N/A (negative equity: EV 422.3m - Net Debt 515.3m = -93.0m; debt exceeds intrinsic value)
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -30.83 | EPS CAGR: -44.10% | SUE: -4.0 | # QB: 0
Revenue Correlation: 4.63 | Revenue CAGR: 2.67% | SUE: -0.56 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.22 | Chg30d=-0.180 | Revisions Net=-1 | Analysts=3
EPS next Year (2026-12-31): EPS=6.25 | Chg30d=-0.034 | Revisions Net=-2 | Growth EPS=+15.2% | Growth Revenue=+8.8%